The seven patients in our cohort exhibit a typical CNTNAP2 core phenotype, including global developmental delay with expressive language disturbances in all (7/7, 100%) and behavioral abnormalities in most (5/7, 71%). The gene discussed is CNTNAP2; the disease is Global developmental delay.